Curcumin is a polyphenol present in the rhizomes of the species Curcuma longa L.
activation (Donadelli et al., 2000) . Moreover, a persistent, chronic, low-grade kidney inflammation often leads to chronic kidney disease (CKD; Akchurin & Kaskel, 2015) . Most cases will respond to treatment with corticosteroids because they inhibit NF-κB activation (Wenderfer, 2012) . However, long-term use of corticosteroids can cause undesirable side effects, such as growth retardation in children.
Therefore, new, safer drugs are needed to treat NS.
One of the most promising anti-inflammatory and immunosuppressive molecules is curcumin (Amirghofran, 2012; Jagetia & Aggarwal, 2007) , a polyphenol present in the rhizomes of Curcuma longa L. ("turmeric," Zingiberaceae), which has been used for centuries as an anti-inflammatory medicine in Asia. Turmeric and curcumin have a myriad of biological effects, including antimicrobial (Vaughn et al., 2017) , anticancer (Hamzehzadeh, Atkin, Majeed, Butler, & Sahebkar, 2018) , antidepressant (Al-Karawi, Al Mamoori, & Tayyar, 2016) , anti-inflammatory, and analgesic in osteoartritis (Dragos et al., 2017) , especially on the circulatory system (Saeidinia et al., 2018; Sukardi et al., 2015; Wongcharoen et al., 2012) and metabolic syndrome (Atkin, Katsiki, Derosa, Maffioli, & Sahebkar, 2017) .
We herein tested the hypothesis that, in an animal model of doxorubicin (DOX)-induced kidney injury, as a surrogate model for NS, the use of curcumin-rich powdered rhizomes of C. longa, mixed in food, results in reduction of albuminuria and renal inflammation, when compared with standard food.
| MATERIALS AND METHODS
Male, 6-to 8-week-old Wistar rats (220-290 g of body weight) were used. They were kept in cages containing three to four rats fed with standard food and offered water ad libitum. For the wake-sleep cycle, the rats were exposed to 12 hr of light and 12 hr of dark, at a temperature of 22°C. Every 2 weeks, the rats were placed in individual metabolic cages for body weight, food intake, and urinary volume measurements. Urine samples were collected for measurement of albumin and creatinine concentrations. The protocol was conducted in accordance with the ethical principles of the National Council for Animal Experimentation Control (CONCEA), the EU Directive 2010/ 63/EU for animal experiments, and was approved by the local animal ethics committee (#057/2014).
| Preparation of Curcuma longa
Rhizomes of C. longa, cultivated in the region of Jardinopolis, São Paulo, Brazil, were collected, washed, sliced, and dried for 7 days in a circulating air oven at 45°C. This species is not protected by law in Brazil. The dried material was powdered in a knife mill up to 42-mesh particle size. Curcumin and desmethoxycurcumin standards were obtained from the rhizomes following the methods described elsewhere (Jayaprakasha, Rao, & Sakariah, 2002) 
| Preparation of food and choice of dose
According to the World Health Organization, the dose of powdered plant material of C. longa for adults is 1.5 to 3.0 g daily (WHO, 1999) We used standard food (Nuvilab®, Curitiba, Brazil), which was crushed in a mill (DPM-4, Nogueira, Itapira, Brazil) with Sieve number 2 and mixed with the powdered C. longa in a proportion of 5 mg per 1 g of food. This proportion was chosen to provide a dose of 250 mg·kg −1 ·day −1 of C. longa, given an average food consumption of 50 g·kg −1 ·day −1 for an adult rat (Carvalho et al., 2009 ).
This mixture was mixed (mixer MA 206, Marconi, Piracicaba, Brazil) for 10 min and then pelletized (Rosim 0337, Rosim, Boa Esperança do Sul, Brazil) back.
| Induction of kidney injury
We used a model of DOX-induced kidney injury as a surrogate model for NS (Bertani et al., 1982; Simic, Tabatabaeifar, & Schaefer, 2013) .
DOX (Fauldoxo®, Libbs, Embu, Brazil) , at 3.5 mg.kg
, was injected IV through the tail dorsal vein on Day 0 (D0). According to Lee and Harris (2011) , the dose of DOX to induce nephropathy in rats ranges between 1.5 and 7.5 mg.kg −1 (Lee & Harris, 2011) . In our study, we selected a dose of 3.5 mg.kg −1 , which was previously used by our group (Galli, Volpini, Costa, da Silva, & Coimbra, 2001) .
The animals were then split into four groups, with 9-10 rats each, as follows: SAL-STD-the rats were treated with normal saline (SAL) and received standard food (STD) during the treatment period (n = 9); SAL-CUR-the rats were treated with SAL and received standard food mixed with C. longa (CUR; n = 10); DOX-STD-the rats were treated with DOX and received standard food (STD; n = 10); and DOX-CUR-the rats were treated with DOX and received standard food mixed with C. longa (CUR; n = 10).
On Day 56, the rats were anesthetized with sodium thiopental (40 mg.kg , i.p.), and after completely sedated, blood and urine samples were collected. A catheter was surgically inserted in the inferior vena cava for blood collection, and another catheter was surgically inserted in the bladder for urine collection. The animals were then sacrificed, and the left kidney was harvested, sectioned, and fixed in methanol-Carnoy (methacarn) solution for 24 hr and stored in 70%
ethanol. Histological sections were made for optical microscopy and immunolabelling for desmin, vimentin, and ED-1 + cells.
| Determination of serum and urinary tests
Urine and serum samples were kept frozen at −70°C until processed. 
| Light microscopy
The histological sections (3 μm) were stained with Masson's trichrome.
Glomerular lesions were evaluated by scores that reflected the extent of the injury (0, 0-5%; 1, 5-25%; 2, 25-50%; 3, 50-75%; or 4, >75%).
Interstitial injuries of the renal cortex were also evaluated by scores (Shih, Hines, & Neilson, 1988; 0, normal; 0.5 
| Immunohistochemistry
The histological sections (3 μm) were dewaxed and subjected to ) and 50 glomeruli were analyzed.
| Statistical analysis
Comparisons between groups were done with one-way (single time point) or two-way (repeated measures) analysis of variance, with
Tukey-Kramer test for multiple comparisons. Some data were logtransformed before statistical analysis because of non-normal distributions. Values of p < 0.05 were considered statistically significant. We used GraphPad Prism 7 software (GraphPad Software Inc., La Jolla, CA, USA).
| RESULTS
Weight gain was lower in DOX-treated animals by approximately 100 g, although this difference was not statistically significant. Food intake did not differ significantly between groups. Drug intake within food was around 400 mg·kg −1 ·day −1 in both groups treated with C. longa (nonsignificant difference, Table 1 ).
All groups had normal levels of serum creatinine and serum and urinary osmolality. Urinary osmolality was significantly lower in the DOX-CUR group when compared with SAL-CUR, and no other difference was found ( Table 2 ).
The urinary albumin/creatinine ratio was significantly higher in sick animals (DOX-STD and DOX-CUR) as compared with that in nonsick animals (SAL-STD and SAL-CUR) from Day 14 on; however, treatment with C. longa did not affect this ratio (Figure 1 ). Note. DOX: doxorubicin; CUR: food with powdered Curcuma longa rhizomes; SAL: normal saline; STD: standard food. Nine animals were studied in group SAL-STD, and 10 animals per group were studied in the other groups. The data were expressed as median (interquartile range).
| Kidney inflammation and injury
Urinary MCP-1/creatinine and TGF-β/creatinine ratios were both significantly higher in sick, nontreated animals (DOX-STD) when compared with those in nonsick animals (SAL-STD and SAL-CUR groups).
Treatment with C. longa (DOX-CUR group) led to a significant reduction on both urinary MCP-1/creatinine and TGF-β/creatinine ratios 
| DISCUSSION
We herein confirmed our hypothesis that oral administration of pow- Our experiment showed that animals with kidney injury treated with C. longa had lower markers of kidney inflammation and injury.
These observations were confirmed by light microscopy, in which we observed attenuation of glomerulosclerosis, tubular atrophy, and interstitial fibrosis, when compared with sick, untreated animals (DOX-STD).
In the groups with DOX-induced kidney injury, albuminuria remained high during the 8 weeks of the experiment. The choice of 8 weeks for the experiment was made to evaluate the animals during the period of absent or mild tissue injury induced by DOX. Our model worked very alike that described in the literature (Bertani et al., 1982; Bertani, Cutillo, Zoja, Broggini, & Remuzzi, 1986; Galli et al., 2001) , with albuminuria appearing in the first weeks. The kidney injury model with DOX causes increased glomerular capillary permeability and tubular atrophy (Noone et al., 2018) , leading to massive proteinuria, hypoalbuminemia, hyperlipidemia, and almost no histological lesion in the first 8 weeks. That is why this model is often used as a surrogate FIGURE 1 Log-transformed albumin/creatinine ratio (mean and standard error of the mean). Nine animals were studied in group SAL-STD, and 10 animals per group were studied in the other groups. DOX: doxorubicin; CUR: food with powdered Curcuma longa rhizomes; SAL: normal saline; STD: standard food; ****: p < 0.0001 for all comparisons between SAL and DOX groups FIGURE 2 (a) MCP-1/creatinine and (b) TGF-β/creatinine ratios at the 56th day. Nine animals were studied in group SAL-STD, and 10 animals per group were studied in the other groups. MCP-1: monocyte chemoattractant protein-1; TGF-β: transforming growth factor-β; DOX: doxorubicin; CUR: food with powdered Curcuma longa rhizomes; SAL: normal saline; STD: standard food; *: p < 0.05; ***: p < 0.001; ****: p < 0.0001 model for NS. However, after 8 weeks, more extensive lesions appear in the kidneys, evolving to FSGS and CKD (Okuda et al., 1986) . In addition, the glomerulonephritis that causes albuminuria in the model with DOX is secondary to drug nephrotoxicity, a different mechanism of proteinuria from that seen in humans with NS. These differences could explain why we did not observe any reduction in albuminuria.
Regarding toxicity, the addition of C. longa to the food resulted in no observable adverse effect to the animals.
Curcumin, the main active constituent of C. longa, besides a myriad of pharmacological properties (Jurenka, 2009; Nelson et al., 2017) , ( Kuptniratsaikul et al., 2014) , atherogenic risk reduction in patients with Type 2 diabetes mellitus (Chuengsamarn, Rattanamongkolgul, Phonrat, Tungtrongchitr, & Jirawatnotai, 2014) , and attenuation of myocardial injury after cardiac surgery (Wongcharoen et al., 2012) . In addition, the plant exhibits protective effects in animal models of myocardial (Tanwar, Sachdeva, Golechha, Kumari, & Arya, 2010; Yang, Wu, Li, & You, 2013) , pulmonary (K. Liu et al., 2012; Sakurai et al., 2013) , and renal injury (Mohamad et al., 2009; Sharma, Kulkarni, & Chopra, 2006) . In rats, C. longa attenuated nephrotoxicity of gentamicin and cisplatin (Elgazar & AboRaya, 2013; Pathak, Rajurkar, Tarekh, & Badgire, 2013) and also protected the heart, liver, and kidneys from DOX-induced toxicity (Mohamad et al., 2009) . Curcumin also protected the kidneys against cadmium-induced nephrotoxicity (K. S. Kim et al., 2018) , ischemia-reperfusion injury (F. Liu et al., 2017) , and, in the form of nanoparticles, against rhabdomyolysis-induced kidney injury (Chen et al., 2018) . In these studies, however, C. longa was used in different ways. In one study, a C. longa extract was administered 10 days prior to the injection of DOX, in a preventive way (Mohamad et al., 2009 ); in another study, an oral suspension of curcumin was used in the reduction of oxidative stress and renal dysfunction in diabetic rats (Sharma et al., 2006) ; and in yet another study, a curcumin solution was injected previously to lipopolysaccharide-induced injury, showing reduction of renal MCP-1 e NF-κB activation (Zhong, Chen, Han, Jin, & Wang, 2011) . This is the first study that, to the best of our knowledge, evaluated the therapeutic efficacy of C. longa, administered after DOX-induction of injury and in the form of powdered dried rhizomes. This means that we investigated the therapeutic, not the prophylactic, effect. In addition, we used powdered plant material; therefore, producing this medicine does not require expensive or complex technology. In fact, there is preclinical evidence that the effect of C. longa is superior to that of isolated curcumin (Martin, Aiyer, Malik, & Li, 2012) . This may be explained because isolated curcumin is poorly soluble in water and has limited bioavailability (Jurenka, 2009) . Curcumin bioavailability can be substantially increased by concomitant administration of piperine (from black pepper, Piper nigrum L.), but the best bioavailability of curcumin has been obtained by mixing it with compounds initially present in turmeric roots that are removed by the puritification process, especially Ar-turmerone (Antony et al., 2008) . This enhanced bioavailability is a result of the inherent synergism between the natural compounds present in the rhizomes (Kiefer, 2007) . Another explanation for a superior effect of C. longa is that other compounds, such as turmerone, can also have therapeutic effects.
In patients with diabetic nephropathy, short-term administration of C. longa attenuated proteinuria and serum levels of TGF-β and interleukin-8 (Khajehdehi et al., 2011) . In patients with chronic renal disease, administration of curcumin was well tolerated and reduced interleukin-6 levels (Moreillon et al., 2013) .
Our results encourage us to conduct a clinical trial to investigate the effectiveness of C. longa to treat idiopathic NS and other forms of inflammatory kidney disease in humans. We can speculate that C. longa can be also useful in other syndromes with proteinuria, because reducing kidney inflammation could lead to a slower progression to CKD. Of course, more studies are needed to confirm these speculations.
In conclusion, the administration of powdered dried rhizomes of C. longa, to rats with DOX-induced renal injury, for 8 weeks, resulted in reduction of urinary markers of renal inflammation MCP-1 and TGF-β, and lower tissue expression of markers of renal injury desmin and vimentin, and a smaller number of ED-1 + cells (macrophages and monocytes) in tubule-interstitial compartment, as well as less renal tissue damage in light microscopy, suggesting an anti-inflammatory effect in the kidneys.
